Research Articles
123 results
Hemostatic imbalance induced by tamoxifen in estrogen receptor-positive breast cancer patients: An observational study
Viscoelastometric Testing to Assess Hemostasis of COVID-19: A Systematic Review.
Waning of IgG, Total and Neutralizing Antibodies 6 Months Post-Vaccination with BNT162b2 in Healthcare Workers.
Validation and standardization of the ETP-based activated protein C resistance test for the clinical investigation of steroid contraceptives in women: an unmet clinical and regulatory need.
Variability among commercial batches of normal pooled plasma in lupus anticoagulant testing.
Vaccine-induced binding and neutralizing antibodies against Omicron 6 months after a homologous BNT162b2 booster.
Update of the International Council for Standardization in Haematology Recommendations for Laboratory Measurement of Direct Oral Anticoagulants.
Usefulness of a Non-Streptavidin Bead Technology to Overcome Biotin Interference: Proof of Principle with 25-OH Vitamin D, TSH, and FT4.
The role of serology for COVID-19 control: Population, kinetics and test performance do matter.
Unexpected kinetics of anti-SARS-CoV-2 total antibodies in two patients with chronic lymphocytic leukemia.
The myths behind DOAC measurement: Analyses of prescribing information from different regulatory bodies and a call for harmonization.
The Risk of Arterial Thrombosis in Patients With Chronic Myeloid Leukemia Treated With Second and Third Generation BCR-ABL Tyrosine Kinase Inhibitors May Be Explained by Their Impact on Endothelial Cells: An In-Vitro Study.
The edoxaban-M4 metabolite and measurement of edoxaban by chromogenic assays in human plasma.
The Impact of Strong Inducers on Direct Oral Anticoagulant Levels.
The DaXa-inhibition assay: A concept for a readily available, universal aXa assay that measures the direct inhibitory effect of all anti-Xa drugs.
Studies on hemostasis in COVID-19 deserve careful reporting of the laboratory methods, their significance, and their limitations.
Study of in vitro thrombin generation after neutralization of heparin.
Spike vs. nucleocapsid serum antigens for COVID-19 diagnosis and severity assessment.
Stability of coagulation parameters in plasma samples at room temperature after one freeze/thaw cycle.
Serum SARS-CoV-2 Antigens for the Determination of COVID-19 Severity
Simultaneous assessment of DOACs effect on clot formation and fibrinolysis with the FibWave.
Response of anti-SARS-CoV-2 total antibodies to nucleocapsid antigen in COVID-19 patients: a longitudinal study.
Risk of neoplasm with the neurokinin 3 receptor antagonist fezolinetant. The Lancet (2023). https://doi.org:10.1016/S0140-6736(23)01634-3
Reduction of the turn-around time for the measurement of rivaroxaban and apixaban: Assessment of the performance of a rapid centrifugation method.
Resistance towards ChadOx1 nCoV-19 in an 83 Years Old Woman Experiencing Vaccine Induced Thrombosis with Thrombocytopenia Syndrome.
Prothrombotic disturbances of hemostasis of patients with severe COVID-19: A prospective longitudinal observational study.
Prothrombotic hemostasis disturbances in patients with severe COVID-19: Individual daily data.
Profile of estetrol, a promising native estrogen for oral contraception and the relief of climacteric symptoms of menopause.
Proof of concept of a new scale for the harmonization and the standardization of the ETP-based APC resistance.
Persistence of Anti-SARS-CoV-2 Antibodies Depends on the Analytical Kit: A Report for Up to 10 Months after Infection.
Post-SARS-CoV-2 vaccination specific antibody decrease – Thresholds for determining seroprevalence and seroneutralization differ.
Performance of a Qualitative Point-of-Care Strip Test to Detect DOAC Exposure at the Emergency Department: A Cohort-Type Cross-Sectional Diagnostic Accuracy Study.
Peri-infection titers of neutralizing and binding antibodies as a predictor of COVID-19 breakthrough infections in vaccinated healthcare professionals: importance of the timing.
Overview and Practical Application of Coagulation Assays in Managing Anticoagulation with Direct Oral Anticoagulants (DOACs).
Oral Contraceptives and Venous Thromboembolism: Focus on Testing that May Enable Prediction and Assessment of the Risk.
Overcoming issues in plasmatic evaluation of direct Factor Xa inhibitors
Nucleocapsid serum antigen determination in SARS-CoV-2 infected patients using the single molecule array technology and prediction of disease severity.
Optimal wavelength for the clot waveform analysis: Determination of the best resolution with minimal interference of the reagents.
NETosis and the Immune System in COVID-19: Mechanisms and Potential Treatments.
Neutralizing Antibodies in COVID-19 Patients and Vaccine Recipients after Two Doses of BNT162b2.
Management of the thrombotic risk associated with COVID-19: guidance for the hemostasis laboratory.
NETosis and Nucleosome Biomarkers in Septic Shock and Critical COVID-19 Patients: An Observational Study.
Low Thrombin Generation in Users of a Contraceptive Containing Estetrol and Drospirenone.
Lung Transplant Recipients Immunogenicity after Heterologous ChAdOx1 nCoV-19-BNT162b2 mRNA Vaccination.
Long-term kinetics of anti-SARS-CoV-2 antibodies in a cohort of 197 hospitalized and non-hospitalized COVID-19 patients.
Long-Term Survival, Vascular Occlusive Events and Efficacy Biomarkers of First-Line Treatment of CML: A Meta-Analysis.
Letter to the Editors-in-Chief in response to the article of Abou-Ismail, et al. entitled “Estrogen and thrombosis: A bench to bedside review” (Thrombosis Research 192 (2020) 40-51).
Laboratory testing in patients treated with direct oral anticoagulants: a practical guide for clinicians.
Kinetics and ability of binding antibody and surrogate virus neutralization tests to predict neutralizing antibodies against the SARS-CoV-2 Omicron variant following BNT162b2 booster administration.
Laboratory Testing for the Evaluation of Phenotypic Activated Protein C Resistance.
Influence of C-reactive protein on thrombin generation assay.
Interlaboratory variability of activated protein C resistance using the ETP-based APC resistance assay.
Importance of sample dilution in the evaluation of the antibody response after SARS-CoV-2 vaccination.
Inflammation-induced coagulopathy substantially differs between COVID-19 and septic shock: a prospective observational study.
Impact of estetrol (E4) on hemostasis, metabolism and bone turnover in postmenopausal women.
Importance of measuring pharmacologically active metabolites of edoxaban: development and validation of an ultra-high-performance liquid chromatography coupled with a tandem mass spectrometry method.
Identification of SARS-CoV-2 Neutralizing Antibody with Pseudotyped Virus-based Test on HEK-293T hACE2 Cells.
Impact of centrifugation on thrombin generation in healthy subjects and in patients treated with direct oral anticoagulants.
Hormone-induced coagulopathy – Evaluation of the prothrombotic state using a global coagulation assay
Hypotheses behind the very rare cases of thrombosis with thrombocytopenia syndrome after SARS-CoV-2 vaccination.
High clinical performance and quantitative assessment of antibody kinetics using a dual recognition assay for the detection of SARS-CoV-2 IgM and IgG antibodies.
Hormonal therapies and venous thrombosis: Estrogen matters!
Head-to-Head Comparison of Rapid and Automated Antigen Detection Tests for the Diagnosis of SARS-CoV-2 Infection.
Fatal exacerbation of ChadOx1-nCoV-19-induced thrombotic thrombocytopenia syndrome after initial successful therapy with intravenous immunoglobulins – a rational for monitoring immunoglobulin G levels.
Head-to-head comparison of cytokines storm-coagulopathy in septic shock and COVID-19.
Evaluation of the effect of a new oral contraceptive containing estetrol and drospirenone on hemostasis parameters.
Evaluations of SARS-CoV-2 Serological Assay Performance Need Inclusion of Long-Term Samples.
Evaluation of the analytical performances of FibWave, a new sensitive tool assessing the fibrin clot formation, to measure the effects of anticoagulants.
Evaluation of the DOAC-Stop(R) Procedure to Overcome the Effect of DOACs on Several Thrombophilia Screening Tests.
Évaluation et prise en charge du risque thrombotique chez les patients hospitalisés atteints de Covid-19.
Evaluation of Activated Protein C Resistance Using Thrombin Generation Test.
Estetrol is not a SERM but a NEST and has a specific safety profile on coagulation.
Estetrol Is Safe and Well Tolerated during Treatment of Hospitalized Men and Women with Moderate COVID-19 in a Randomized, Double-Blind Study.
Efficient Maternal to Neonate Transfer of Neutralizing Antibodies after SARS-CoV-2 Vaccination with BNT162b2: A Case-Report and Discussion of the Literature.
Estetrol (E4) is a native fetal estrogen that does not modify coagulation markers in postmenopausal women and maintains sensitivity to activated protein C (APC).
Effect of tissue factor pathway inhibitor on thrombin generation assay.
Early antibody response in health-care professionals after two doses of SARS-CoV-2 mRNA vaccine (BNT162b2).
Durability of humoral and cellular immunity six months after the BNT162b2 bivalent booster
Dynamics of Neutralizing Antibody Responses Following Natural SARS-CoV-2 Infection and Correlation with Commercial Serologic Tests. A Reappraisal and Indirect Comparison with Vaccinated Subjects.
Development of the FibWave, an improved clot waveform analysis for the assessment of hemostasis
Dexamethasone Modulates the Cytokine Response but Not COVID-19-Induced Coagulopathy in Critically Ill.
Determinants of the Quality of Warfarin Control after Venous Thromboembolism and Validation of the SAMe-TT2-R2 Score: An Analysis of Hokusai-VTE.
Development of new methodologies for the chromogenic estimation of betrixaban concentrations in plasma.
Detection of Direct Oral Anticoagulants in Patient Urine Samples by Prototype and Commercial Test Strips for DOACs – A Systematic Review and Meta-analysis.
D-dimer Testing in Pulmonary Embolism with a Focus on Potential Pitfalls: A Narrative Review.
Confounding Factors Influencing the Kinetics and Magnitude of Serological Response Following Administration of BNT162b2.
Contraceptifs oraux combinés et thrombo-embolie veineuse: quels sont vriament les risques?
Comprehensive review of the impact of direct oral anticoagulants on thrombophilia diagnostic tests: Practical recommendations for the laboratory.
Concomitant assessment of rivaroxaban concentration and its impact on thrombin generation.
Comparison is not reason: Pitfalls in reporting thrombin generation results in anticoagulated patients.
Comparison of analytical performances between clot waveform analysis and FibWave in edoxaban-treated patients and healthy controls.
Combined Oral Contraceptives and Venous Thromboembolism: Review and Perspective to Mitigate the Risk.
Comment on “Favresse et al. Persistence of Anti-SARS-CoV-2 Antibodies Depends on the Analytical Kit: A Report for Up to 10 Months after Infection. Microorganisms 2021, 9, 556”.
Clinical performance of the Panbio assay for the detection of SARS-CoV-2 IgM and IgG in COVID-19 patients.
Clinical performance of three fully automated anti-SARS-CoV-2 immunoassays targeting the nucleocapsid or spike proteins.
Clinical performance evaluation of the Fluorecare(R) SARS-CoV-2 & Influenza A/B & RSV rapid antigen combo test in symptomatic individuals.
Clinical Performance of the Elecsys Electrochemiluminescent Immunoassay for the Detection of SARS-CoV-2 Total Antibodies.
Clinical Chemistry and Laboratory Medicine celebrates 60 years – narrative review devoted to the contribution of the journal to the diagnosis of SARS-CoV-2.
Can We Measure the Individual Prothrombotic or Prohemorrhagic Tendency by Global Coagulation Tests?
Cellular immunity against SARS-CoV-2 is predominantly boosted in vaccinated individuals with no history of infection.
BCR-ABL Tyrosine Kinase Inhibitors: Which Mechanism(s) May Explain the Risk of Thrombosis?
Betrixaban: Impact on Routine and Specific Coagulation Assays-A Practical Laboratory Guide.
Assessment of the humoral response in Omicron breakthrough cases in healthcare workers who received the BNT162b2 booster.
Association of cardiovascular occlusive events with BCR-ABL tyrosine kinase therapy – Identification, understanding and prediction.
Assessment of low plasma concentrations of apixaban in the periprocedural setting.
Assessment of the analytical performances and sample stability on ST Genesia system using the STG-DrugScreen application.
Anticoagulation With an Inhibitor of Factors XIa and XIIa During Cardiopulmonary Bypass.
Are the DOAC plasma level thresholds appropriate for clinical decision-making? A reappraisal using thrombin generation testing.
Antibody titres decline 3-month post-vaccination with BNT162b2.
Analytical performance of the endogenous thrombin potential-based activated protein C resistance assay on the automated ST Genesia system.
Analytical Sensitivity of Six SARS-CoV-2 Rapid Antigen Tests for Omicron versus Delta Variant.
An update on laboratory assessment for direct oral anticoagulants (DOACs).
Analytical and clinical validation of an ELISA for specific SARS-CoV-2 IgG, IgA, and IgM antibodies.
An original multiplex method to assess five different SARS-CoV-2 antibodies.
An Original ELISA-Based Multiplex Method for the Simultaneous Detection of 5 SARS-CoV-2 IgG Antibodies Directed against Different Antigens.
